Variant report
Variant | nsv436409 |
---|---|
Chromosome Location | chr4:94559130-94567135 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546662025 | chr4:94565401-94565402 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560330409 | chr4:94565426-94565427 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529408488 | chr4:94565452-94565453 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549161015 | chr4:94565453-94565454 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569490332 | chr4:94565468-94565469 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538514735 | chr4:94565469-94565470 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551118446 | chr4:94565511-94565512 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150615035 | chr4:94565512-94565513 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11387483 | chr4:94565517-94565518 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113664740 | chr4:94565542-94565543 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533663519 | chr4:94565543-94565544 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150337205 | chr4:94565564-94565565 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13136588 | chr4:94565580-94565581 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs547466547 | chr4:94565581-94565582 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77012383 | chr4:94565584-94565585 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192645764 | chr4:94565604-94565605 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375076569 | chr4:94565617-94565618 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545266575 | chr4:94565683-94565684 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569712047 | chr4:94565701-94565702 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564345467 | chr4:94565702-94565703 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182813338 | chr4:94565746-94565747 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577936287 | chr4:94565760-94565761 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17020910 | chr4:94565766-94565767 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560258545 | chr4:94565776-94565777 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367893557 | chr4:94565792-94565793 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529337017 | chr4:94565799-94565800 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187530727 | chr4:94565811-94565812 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563075934 | chr4:94565824-94565825 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113217373 | chr4:94565834-94565835 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552014348 | chr4:94565846-94565847 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13112912 | chr4:94565878-94565879 | Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs571055437 | chr4:94565898-94565899 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527237100 | chr4:94565899-94565900 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17291977 | chr4:94565915-94565916 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72891205 | chr4:94565939-94565940 | Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs559964147 | chr4:94565968-94565969 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374791732 | chr4:94566038-94566039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536339958 | chr4:94566077-94566078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2117703 | chr4:94566117-94566118 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs569804492 | chr4:94566142-94566143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12710872 | chr4:94566151-94566152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs558776143 | chr4:94566194-94566195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542284146 | chr4:94566212-94566213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138045201 | chr4:94566258-94566259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372738467 | chr4:94566268-94566269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540269914 | chr4:94566277-94566278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184729391 | chr4:94566314-94566315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17020913 | chr4:94566321-94566322 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs542680585 | chr4:94566345-94566346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs189594285 | chr4:94566373-94566374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Epilepsy | 20502679 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:94565400-94565800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:94565400-94566000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
3 | chr4:94565400-94567000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr4:94565800-94566200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr4:94565800-94566600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:94566000-94566200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:94566000-94567800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr4:94566200-94570600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:94566200-94570600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr4:94566600-94567200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:94567000-94570600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |